ALK-Directed Therapy in Non-NSCLC Malignancies: Are We Ready?
- PMID: 34994610
- DOI: 10.1200/PO.21.00078
ALK-Directed Therapy in Non-NSCLC Malignancies: Are We Ready?
Conflict of interest statement
Comment on
-
Impact of ALK Inhibitors in Patients With ALK-Rearranged Nonlung Solid Tumors.JCO Precis Oncol. 2021 May 3;5:PO.20.00383. doi: 10.1200/PO.20.00383. eCollection 2021. JCO Precis Oncol. 2021. PMID: 34036223 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
